Search results
U.S. FDA grants full approval to Pfizer COVID vaccine for ages 12-15
Reuters via Yahoo News· 2 years agoThe vaccine, sold under the brand name Comirnaty for adults, has been available under an emergency...
Novavax's Covid-19 Vaccine Cleared For Use In New Zealanders Aged 12-17
Benzinga via Yahoo Finance· 2 years agoNew Zealand's Medsafe has granted expanded provisional approval for Novavax Inc's (NASDAQ: NVAX)...
Pharma Stock Roundup: MRK Buys Cancer Drug Rights, SNY Dupixent Kids Study Succeeds
Zacks via Yahoo Finance· 2 years agoThis week, Merck MRK in-licensed co-development rights to Orion Corporation’s prostate cancer...
PFE, BNTX and MRNA Omicron Boosters Get Positive CHMP Opinion
Zacks via Yahoo Finance· 2 years agoIt has been a good week for leading COVID-19 vaccine makers, Pfizer PFE /BioNTech BNTX and Moderna...
PFE, BNTX's COVID Jab Gets FDA's Full Nod for Adolescents
Zacks via Yahoo Finance· 2 years agoPfizer (PFE) and partner BioNTech's (BNTX) Comirnaty is the first COVID-19 vaccine to receive full...
Moderna's (MRNA) COVID Jab Gets Nod For Kids in Canada
Zacks via Yahoo Finance· 2 years agoModerna MRNA received approval from Canadian regulatory authority, Health Canada, for its mRNA...
How long it took to develop 13 vaccines in history
Business Insider via Yahoo News· 11 months agoA pharmacist prepares the Pfizer-BioNTech vaccine.Jessica Hill/AP Photo Scientists raced to develop COVID-19 vaccines at record speed. Vaccines often...
Patients file lawsuits in Charlotte court alleging issues caused by Merck’s HPV vaccines
Charlotte Observer via Yahoo News· 3 months agoA vaccine manufactured in North Carolina — and the only one given to protect against human...
Moderna Surges 14% After Covid Vaccine-Maker Surprises With Fourth-Quarter Profit
Investor's Business Daily· 4 months agoModerna stock surged Thursday after the Covid vaccine-maker beat Wall Street's quarterly...
Novavax's COVID-19 Vaccine Gets Complete Approval From European Commission
Benzinga via Yahoo Finance· 11 months agoThe European Commission has approved Novavax Inc's (NASDAQ: NVAX) Nuvaxovid (NVX-CoV2373), following...